Monday, April 19, 2021

This website uses cookies. By using our site you agree to our privacy policy

Username:

Password:

Lost username/password
Create an account

Home
About Us
Mission Statement
Clinical Advisors
Contributing Faculty
Awards
Accreditation
Contact Us
CE Education
REMS in Primary Care
-- Archives --
A New Era of Migraine Management: The Changing Landscape of Prevention
The Promise of CGRP Antibodies to Change Practice in Migraine Treatment
Case Studies in Migraine
Clinical Challenges in Migraine: The Role of Emerging Therapies in New Treatment Paradigms
Clinical Dialogues in Pain - OIC
Therapeutic Advances and Evolving Treatment Strategies: Novel Approaches to Migraine Management
Targeting CGRP: Emerging Solutions in Migraine
How to Talk to Your Patients About Opioid-induced Constipation: A Dialogue About New Advances
Patient-Centered Approaches to Treatment of Migraine: Real-World Cases with Real-World Challenges
Resources
Resource Links
Migraine Pain
Migraine Resources
Friedman Downloadable Slides
Charles Downloadable Slides
Migraine FDA Watch

What's New

Migraine Pain
Migraine FDA Watch
New migraine therapies approved by the FDA

Migraine Pain
Preventive Treatment in Migraine Today
Deborah I. Friedman, MD, MPH, FAAN

Migraine
FDA Watch

Three new therapies have received FDA approval in 2018. Catch up with our concise summary covering the approval of erenumab, fremanezumab, and galcanezumab.

©2021 MediCom Worldwide, Inc.

Contact Us
Privacy, Terms and Conditions